Tue November 10, 2020
Japan's Innovations for an Aging Society - Free Online Event
SEE EVENT DETAILS
Presented by The Center for Asian Health Research and Education in partnership with Stanford Health Library
Japan is the most rapidly aging developed society in the world. Currently, the population 65 years and older in Japan accounts for approximately 29 percent of the total population, and by 2050 it will be 40 percent. As these rapid changes occur, Japan is innovating ways to solve the unmet needs of an aging society. Dr. Ikeno, a Research Associate in Cardiovascular Medicine at Stanford University and the founder of a Japanese biodesign company that is addressing these issues, will discuss some of these innovations.
Fumiaki Ikeno, MD, is a Research Associate in Cardiovascular Medicine at Stanford University and the Program Director (U.S) Japan Biodesign, Stanford Biodesign.
show less
Japan is the most rapidly aging developed society in the world. Currently, the population 65 years and older in Japan accounts for approximately 29 percent of the total population, and by 2050 it will be 40 percent. As these rapid changes occur, Japan is innovating ways to solve the unmet needs of an aging society. Dr. Ikeno, a Research Associate in Cardiovascular Medicine at Stanford University and the founder of a Japanese biodesign company that is addressing these issues, will discuss some of these innovations.
Fumiaki Ikeno, MD, is a Research Associate in Cardiovascular Medicine at Stanford University and the Program Director (U.S) Japan Biodesign, Stanford Biodesign.
Presented by The Center for Asian Health Research and Education in partnership with Stanford Health Library
Japan is the most rapidly aging developed society in the world. Currently, the population 65 years and older in Japan accounts for approximately 29 percent of the total population, and by 2050 it will be 40 percent. As these rapid changes occur, Japan is innovating ways to solve the unmet needs of an aging society. Dr. Ikeno, a Research Associate in Cardiovascular Medicine at Stanford University and the founder of a Japanese biodesign company that is addressing these issues, will discuss some of these innovations.
Fumiaki Ikeno, MD, is a Research Associate in Cardiovascular Medicine at Stanford University and the Program Director (U.S) Japan Biodesign, Stanford Biodesign.
read more
Japan is the most rapidly aging developed society in the world. Currently, the population 65 years and older in Japan accounts for approximately 29 percent of the total population, and by 2050 it will be 40 percent. As these rapid changes occur, Japan is innovating ways to solve the unmet needs of an aging society. Dr. Ikeno, a Research Associate in Cardiovascular Medicine at Stanford University and the founder of a Japanese biodesign company that is addressing these issues, will discuss some of these innovations.
Fumiaki Ikeno, MD, is a Research Associate in Cardiovascular Medicine at Stanford University and the Program Director (U.S) Japan Biodesign, Stanford Biodesign.
show less
Date/Times:
Online - Virtual Event
1 Upcoming Events
., San Francisco, CA .
The Best Events
Every Week in Your Inbox
From Our Sponsors
UPCOMING EVENTS
Great suggestion! We'll be in touch.
Event reviewed successfully.